RBCK1 and viral infectious disease: The resultant TDP35 enhances nuclear IRF3 levels by degrading Rbck1 pre-mRNA, thus averting the proteasomal degradation of IRF3 during viral infection and selectively promoting antiviral IFN-I production [33].